Modulation of Nrf2/ARE pathway by food polyphenols: A nutritional neuroprotective strategy for cognitive and neurodegenerative disorders

Molecular Neurobiology

Volumn 44, Issue 2, 2011, Pages 192-201

  Scapagnini, Giovanni ^a   Sonya, Vasto ^b   Nader, Abraham G ^c   Calogero, Caruso ^b   Zella, Davide ^e   Fabio, Galvano ^d  

^a UNIVERSITY OF MOLISE   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c MEDICAL COLLEGE OF OHIO   (United States)

^d UNIVERSITY OF CATANIA   (Italy)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

( ) epigallocatechin 3 gallate (EGCG); Alzheimer's disease; Antioxidant responsive element (ARE); Brain ageing; Curcumin; Heme oxygenase 1 (HO 1); Heterodimers of NF E2 related factors 2 (Nrf2); Neurodegenerative disorders; Polyphenols

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; BARDOXOLONE; BILIVERDIN; CAFFEIC ACID PHENETHYL ESTER; CARNOSOL; CINNAMIC ACID DERIVATIVE; CURCUMIN; ELECTROPHILE; EPIGALLOCATECHIN GALLATE; FERULIC ACID; FLAVONOID; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; HEME OXYGENASE 1; HEME OXYGENASE 2; KELCH LIKE ECH ASSOCIATED PROTEIN 1; OXIDOPAMINE; PLUMBAGIN; POLYPHENOL DERIVATIVE; ROSEOLIC ACID; SULFORAPHANE; TRANSCRIPTION FACTOR NRF2; ZERUMBONE;

ADULT; ALLERGIC ENCEPHALOMYELITIS; ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; ASTROCYTE; BRAIN CELL; BROCCOLI; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CELLULAR STRESS RESPONSE; COGNITION; COGNITIVE DEFECT; DEMENTIA; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE COURSE; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; FOOD COMPOSITION; FRUIT; HIPPOCAMPUS; HUMAN; HUNTINGTON CHOREA; IMMUNOMODULATION; LIPID PEROXIDATION; MEDITERRANEAN DIET; MORTALITY; MOTOR PERFORMANCE; NERVE CELL; NERVE DEGENERATION; NEUROMODULATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PARALYSIS; PATHOGENESIS; PROTEIN EXPRESSION; REMISSION; TEA; VEGETABLE; VIRAL GENE DELIVERY SYSTEM;

EID: 80054875266     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-011-8181-5     Document Type: Article

References (124)

1. Alzheimer's Association 2009 Alzheimer's disease facts and figures Alzheimers Dement 5 234 270 10.1016/j.jalz.2009.03.001
2. LE Rojo, et al. 2008 Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease Arch Med Res 39 1 16 18067990 1:CAS:528:DC%2BD2sXhsVSmtbvM 10.1016/j.arcmed.2007.10.001 (Pubitemid 350192021)
3. DA Butterfield, et al. 2001 Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide Trends Mol Med 7 548 554 11733217 1:CAS:528:DC%2BD3MXovVCnu7o%3D 10.1016/S1471-4914(01)02173-6 (Pubitemid 33127140)
4. B Halliwell 2007 Biochemistry of oxidative stress Biochem Soc Trans 35 1147 1150 17956298 1:CAS:528:DC%2BD2sXht1eru7vN 10.1042/BST0351147 (Pubitemid 350206447)
5. DA Butterfield R Sultana 2007 Redox proteomics identification of oxidatively modified brain proteins in Alzheimer's disease and mild cognitive impairment: insights into the progression of this dementing disorder J Alzheimers Dis 12 61 72 17851195 1:CAS:528:DC%2BD2sXhtV2isb7J (Pubitemid 47396301)
6. R Katzman T Saitoh 1991 Advances in Alzheimer's disease FASEB J 5 278 286 2001787 1:CAS:528:DyaK3MXhs1WksLo%3D (Pubitemid 21892887)
7. T Finkel NJ Holbrook 2000 Oxidants, oxidative stress and the biology of aging Nature 408 239 247 11089981 1:CAS:528:DC%2BD3cXotFGltb0%3D 10.1038/35041687
8. V Calabrese, et al. 2004 Nitric oxide and cellular stress response in brain aging and neurodegenerative disorders: the role of vitagenes In Vivo 18 245 267 15341181 1:CAS:528:DC%2BD2cXmvF2rsr8%3D
9. DM Skovronsky VM Lee JQ Trojanowski 2006 Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications Annu Rev Pathol 1 151 170 18039111 1:CAS:528:DC%2BD28XktVOitbo%3D 10.1146/annurev.pathol.1.110304. 100113
10. M Racchi, et al. 2008 Alzheimer's disease; new diagnostic and therapeutic tools Immun Ageing 5 7 18700965 10.1186/1742-4933-5-7 1:CAS:528: DC%2BD1cXht1amtL3I
11. GT Vatassery S Fahn MA Kuskowski 1998 The Parkinson Study Group. Alpha tocopherol in CSF of subjects taking high dose vitamin E in the DATATOP study Neurology 50 1900 1902 9633757 1:CAS:528:DyaK1cXktFOisbc%3D (Pubitemid 28283281)
12. JA Johnson, et al. 2008 The Nrf2-ARE pathway: An indicator and modulator of oxidative stress in neurodegeneration Ann NY Acad Sci 1147 61 69 19076431 1:CAS:528:DC%2BD1MXhsVaqtbw%3D 10.1196/annals.1427.036
13. NG Innamorato, et al. 2008 The transcription factor Nrf2 is a therapeutic target against brain inflammation J Immunol 181 1 680 689 18566435 1:CAS:528:DC%2BD1cXnsVGitL0%3D
14. Z Sun, et al. 2007 Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2 Mol Cell Biol 27 6334 6349 17636022 1:CAS:528:DC%2BD2sXhtVKls7jP 10.1128/MCB.00630-07 (Pubitemid 47435741)
15. T Yamamoto, et al. 2008 Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity Mol Cell Biol 28 2758 2770 18268004 1:CAS:528:DC%2BD1cXksFWqt7w%3D 10.1128/MCB.01704-07 (Pubitemid 351542373)
16. D Malhotra, et al. 2010 Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis Nucleic Acids Res 38 17 5718 5734 20460467 1:CAS:528:DC%2BC3cXht1WhsLvJ 10.1093/nar/gkq212
17. RJ Jakel, et al. 2007 Nrf2-mediated protection against 6-hydroxydopamine Brain Res 1144 192 201 17336276 1:CAS:528:DC%2BD2sXjsVWhtbs%3D 10.1016/j.brainres.2007.01.131 (Pubitemid 46440842)
18. NG Innamorato, et al. 2010 Different susceptibility to the Parkinson's toxin MPTP in mice lacking the redox master regulator Nrf2 or its target gene heme oxygenase-1 PLoS ONE 5 7 e11838 20676377 10.1371/journal.pone.0011838 1:CAS:528:DC%2BC3cXpvV2qu7w%3D
19. AI Rojo, et al. 2010 Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease Glia 58 5 588 598 19908287
20. MR Vargas, et al. 2006 Increased glutathione biosynthesis by Nrf2 activation in astrocytes prevents p75NTR-dependent motor neuron apoptosis J Neurochem 97 3 687 696 16524372 1:CAS:528:DC%2BD28XkslCjsrk%3D 10.1111/j.1471-4159.2006.03742.x
21. MR Vargas, et al. 2008 Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis J Neurosci 28 50 13574 13581 19074031 1:CAS:528:DC%2BD1cXhsFCqsb7N 10.1523/JNEUROSCI.4099-08.2008
22. CP Ramsey, et al. 2007 Expression of Nrf2 in neurodegenerative diseases J Neuropathol Exp Neurol 66 75 85 17204939 1:CAS:528:DC%2BD2sXhsV2qtb4%3D 10.1097/nen.0b013e31802d6da9 (Pubitemid 46066791)
23. K Kanninen, et al. 2008 Nuclear factor erythroid 2-related factor 2 protects against beta amyloid Mol Cell Neurosci 39 302 313 18706502 1:CAS:528:DC%2BD1cXht1Klt7jE 10.1016/j.mcn.2008.07.010
24. CJ Wruck, et al. 2008 Kavalactones protect neural cells against amyloid beta peptideinduced neurotoxicity via extracellular signal-regulated kinase 1/2-dependent nuclear factor erythroid 2-related factor 2 activation Mol Pharmacol 73 1785 1795 18334601 1:CAS:528:DC%2BD1cXms1ems7g%3D 10.1124/mol.107.042499 (Pubitemid 351724366)
25. K Kanninen, et al. 2009 Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease Proc Natl Acad Sci USA 106 16505 16510 19805328 1:CAS:528: DC%2BD1MXht1Kqtb7N 10.1073/pnas.0908397106
26. PC Chen, et al. 2009 Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte Proc Natl Acad Sci USA 106 2933 2938 19196989 1:CAS:528:DC%2BD1MXislSkurg%3D 10.1073/pnas. 0813361106
27. NG Abraham A Kappas 2008 Pharmacological and clinical aspects of heme oxygenase Pharmacol Rev 60 1 79 127 18323402 1:CAS:528:DC%2BD1cXks1Gjsb8%3D 10.1124/pr.107.07104 (Pubitemid 351439218)
28. M Takahashi, et al. 2002 Amyloid precursor proteins inhibit heme oxygenase activity and augment neurotoxicity in Alzheimer's disease Neuron 28 461 473 10.1016/S0896-6273(00)00125-2
29. HM Schipper 2000 Heme oxygenase-1: role in brain aging and neurodegeneration Exp Gerontol 35 821 830 11053673 1:CAS:528: DC%2BD3cXot1Wqtrk%3D 10.1016/S0531-5565(00)00148-0
30. C Colombrita, et al. 2003 Regional rat brain distribution of heme oxygenase-1 and manganese superoxide dismutase mRNA: relevance of redox homeostasis in the aging processes Exp Biol Med 228 517 524 1:CAS:528: DC%2BD3sXls1Wksb4%3D (Pubitemid 37203670)
31. K Chen K Gunter MD Maines 2000 Neurons overexpressing heme oxygenase-1 resist oxidative stress-mediated cell death J Neurochem 75 304 312 10854275 1:CAS:528:DC%2BD3cXkt12qtLk%3D 10.1046/j.1471-4159.2000.0750304.x (Pubitemid 30418197)
32. WD Le WJ Xie SH Appel 1999 Protective role of heme oxygenase-1 in oxidative stress-induced neuronal injury J Neurosci Res 56 652 658 10374820 1:CAS:528:DyaK1MXjsVOnurg%3D 10.1002/(SICI)1097-4547(19990615)56:6<652::AID- JNR11>3.0.CO;2-5 (Pubitemid 29246847)
33. D Willis, et al. 1996 Heme oxygenase: a novel target for the modulation of the inflammatory response Nat Med 2 87 90 8564848 1:CAS:528: DyaK28XivVSmtg%3D%3D 10.1038/nm0196-87 (Pubitemid 26029572)
34. KD Poss S Tonegawa 1997 Reduced stress defense in heme oxygenase 1-deficient cells Proc Natl Acad Sci USA 94 10925 10930 9380736 1:CAS:528:DyaK2sXmtlCnsbg%3D 10.1073/pnas.94.20.10925 (Pubitemid 27430837)
35. A Yachie, et al. 1999 Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 defi- ciency J Clin Invest 103 129 135 9884342 1:CAS:528:DyaK1MXjsl2lsA%3D%3D 10.1172/JCI4165 (Pubitemid 29031171)
36. A Paine, et al. 2010 Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential Biochem Pharmacol 80 12 1895 1903 20643109 1:CAS:528:DC%2BC3cXhtlKrs77P 10.1016/j.bcp.2010.07.014
37. A Pamplona, et al. 2007 Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria Nat Med 13 6 703 710 17496899 1:CAS:528:DC%2BD2sXmtFeksLw%3D 10.1038/nm1586 (Pubitemid 46889755)
38. AA Chora, et al. 2007 Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation J Clin Invest 117 2 438 47 17256058 1:CAS:528:DC%2BD2sXhs1Oqtrg%3D 10.1172/JCI28844 (Pubitemid 46203972)
39. M Dumont, et al. 2009 Triterpenoid CDDOmethylamide improves memory and decreases amyloid plaques in a transgenic mouse model of Alzheimer's disease J Neurochem 109 2 502 512 19200343 1:CAS:528:DC%2BD1MXksVKgu70%3D 10.1111/j.1471-4159.2009.05970.x
40. TG Son, et al. 2010 Plumbagin, a novel Nrf2/ARE activator, protects against cerebral ischemia J Neurochem 112 5 1316 1326 20028456 1:CAS:528:DC%2BC3cXisVCis7o%3D 10.1111/j.1471-4159.2009.06552.x
41. CD Morrison, et al. 2010 High fat diet increases hippocampal oxidative stress and cognitive impairment in aged mice: implications for decreased Nrf2 signaling J Neurochem 114 6 1581 1589 20557430 1:CAS:528:DC%2BC3cXhtFylu7fO 10.1111/j.1471-4159.2010.06865.x
42. J Zhao, et al. 2007 Enhancing expression of Nrf2-driven genes protects the blood brain barrier after brain injury J Neurosci 27 10240 10248 17881530 1:CAS:528:DC%2BD2sXhtFahsbfE 10.1523/JNEUROSCI.1683-07.2007 (Pubitemid 47450456)
43. P Dash, et al. 2009 Sulforaphane improves cognitive function administered following traumatic brain injury Neurosci Lett 460 2 103 107 19515491 1:CAS:528:DC%2BD1MXnsFajtL8%3D 10.1016/j.neulet.2009.04.028
44. Z Ping, et al. 2010 Sulforaphane protects brains against hypoxic-ischemic injury
45. F Gomez-Pinilla 2008 Brain foods: the effects of nutrients on brain function Nat Rev Neurosci 9 568 578 18568016 1:CAS:528:DC%2BD1cXnsFCgsr0%3D 10.1038/nrn2421 (Pubitemid 351873468)
46. N Nakatani 2000 Phenolic antioxidants from herbs and spices Biofactors 13 141 146 11237173 1:CAS:528:DC%2BD3MXksVOlsL8%3D 10.1002/biof.5520130123 (Pubitemid 32107358)
47. D Butterfield, et al. 2002 Nutritional approaches to combat oxidative stress in Alzheimer's disease J Nutr Biochem 13 444 461 12165357 1:CAS:528:DC%2BD38XmtVWmurc%3D 10.1016/S0955-2863(02)00205-X (Pubitemid 34876979)
48. AY Sun, et al. 2008 Botanical phenolics and brain health Neuromolecular Med 10 259 274 19191039 1:CAS:528:DC%2BD1MXhtlKktw%3D%3D 10.1007/s12017-008- 8052-z
49. K Van Dyk M Sano 2007 The impact of nutrition on cognition in the elderly Neurochem Res 32 893 904 17342414 1:CAS:528:DC%2BD2sXjtlymtrw%3D 10.1007/s11064-006-9241-5 (Pubitemid 46481315)
50. L Letenneur, et al. 2007 Flavonoid intake and cognitive decline over a 10-year period Am J Epidemiol 165 1364 1371 17369607 1:STN:280: DC%2BD2szitl2ntg%3D%3D 10.1093/aje/kwm036 (Pubitemid 47234313)
51. P Barberger-Gateau, et al. 2007 Dietary patterns and risk of dementia: the Three-City cohort study Neurology 69 921 930 10.1212/01.wnl.0000278116. 37320.52 (Pubitemid 350100350)
52. N Scarmeas, et al. 2006 Mediterranean diet, alzheimer disease, and vascular mediation Arch Neurol 63 1709 1717 17030648 10.1001/archneur.63.12. noc60109 (Pubitemid 44925078)
53. JH Kang A Ascherio F Grodstein 2005 Fruit and vegetable consumption andcognitive decline in aging women Ann Neurol 57 713 720 15852398 10.1002/ana.20476 (Pubitemid 40628860)
54. D Commenges, et al. 2000 Intake of flavonoids and risk of dementia Eur J Epidemiol 16 357 363 10959944 1:CAS:528:DC%2BD3cXmsVWisLY%3D 10.1023/A:1007614613771 (Pubitemid 30648741)
55. J Kim HJ Lee KW Lee 2010 Naturally occurring phytochemicals for the prevention of Alzheimer's disease J Neurochem 112 6 1415 30 20050972 1:CAS:528:DC%2BC3cXjsFaku74%3D 10.1111/j.1471-4159.2009.06562.x
56. MP Mattson TG Son S Camandola 2007 Viewpoint: mechanisms of action and therapeutic potential of neurohormetic phytochemicals Dose Response 5 3 174 186 18648607 1:CAS:528:DC%2BD2sXhtVOmsr%2FE 10.2203/dose-response.07-004.Mattson
57. EJ Calabrese 2008 Neuroscience and hormesis: overview and general findings Crit Rev Toxicol 38 4 249 52 18432418 1:CAS:528:DC%2BD1cXltFCmt7c%3D 10.1080/10408440801981957 (Pubitemid 351574461)
58. SI Rattan RA Fernandes D Demirovic B Dymek CF Lima 2009 Heat stress and hormetin-induced hormesis in human cells: effects on aging, wound healing, angiogenesis, and differentiation Dose Response 7 1 90 103 19343114 1:CAS:528:DC%2BC3cXnt1KntL0%3D 10.2203/dose-response.08-014.Rattan
59. D Martin, et al. 2004 Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol J Biol Chem 279 8919 8929 14688281 1:CAS:528:DC%2BD2cXhs1Onurs%3D 10.1074/jbc.M309660200 (Pubitemid 38295953)
60. YJ Surh JK Kundu HK Na 2008 Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals Planta Med 74 13 1526 1539 18937164 1:CAS:528:DC%2BD1cXhtl2hsb3M 10.1055/s-0028-1088302
61. R Foresti, et al. 2005 Differential activation of heme oxygenase-1 by chalcones and rosolic acid in endothelial cells J Pharmacol Exp Ther 312 686 693 15537827 1:CAS:528:DC%2BD2MXhsVCntrs%3D 10.1124/jpet.104.074153 (Pubitemid 40189567)
62. HPT Ammon MA Wahl 1991 Pharmacology of Curcuma Longa Planta Med 57 1 7 2062949 1:CAS:528:DyaK3MXltVGgs7Y%3D 10.1055/s-2006-960004
63. KI Priyadarsini SN Guha MN Rao 1998 Physicochemical properties and antioxidant activities of methoxy phenols Free Radic Biol Med 24 933 941 9607603 1:STN:280:DyaK1c3mvVKiuw%3D%3D 10.1016/S0891-5849(97)00382-1 (Pubitemid 28186233)
64. S Martin-Aragon JM Benedi AM Villar 1997 Modifications on antioxidant capacity and lipid peroxidation in mice under fraxetin treatment J Pharm Pharmacol 49 49 52 9120770 1:CAS:528:DyaK2sXhtVygs74%3D 10.1111/j.2042-7158. 1997.tb06751.x (Pubitemid 27051030)
65. A Sreejayan MN Rao 1997 Nitric oxide scavenging by curcuminoids J Pharm Pharmacol 49 105 107 9120760 1:CAS:528:DyaK2sXhtVymtrY%3D 10.1111/j.2042-7158. 1997.tb06761.x (Pubitemid 27051040)
66. BL Zhao, et al. 1989 Scavenging effect of extracts of green tea and natural antioxidants on active oxygen radicals Cell Biophys 14 175 185 2472207 1:CAS:528:DyaL1MXmtlSrs74%3D
67. T Masuda, et al. 1999 Chemical studies on antioxidant mechanism of curcuminoid: analysis of radical reaction products from curcumin J Agric Food Chem 47 71 77 10563852 1:CAS:528:DyaK1cXotVCrt7Y%3D 10.1021/jf9805348 (Pubitemid 29179626)
68. SV Jovanovic, et al. 2001 How curcumin works preferentially with soluble antioxidants J Am Chem Soc 123 3064 3068 11457017 1:CAS:528:DC%2BD3MXhs1ymtrw%3D 10.1021/ja003823x (Pubitemid 32879574)
69. PB Pun, et al. 2010 Ageing in nematodes: do antioxidants extend lifespan in Caenorhabditis elegans? Biogerontology 11 17 30 19350411 10.1007/s10522-009- 9223-5
70. M Ramos-Gomez, et al. 2001 Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice Proc Natl Acad Sci USA 98 3410 3415 11248092 1:CAS:528:DC%2BD3MXit1altb8%3D 10.1073/pnas.051618798 (Pubitemid 32220859)
71. S Singh BB Aggarwal 1995 Activation of transcription factor NF-κB is suppressed by curcumin (diferuloylmethane) J Biol Chem 270 24995 25000 7559628 1:CAS:528:DyaK2MXovFWmsb8%3D 10.1074/jbc.270.25.14867
72. MT Huang HL Newmark K Frenkel 1997 Inhibitory effects of curcumin on tumorigenesis in mice J Cell Biochem Suppl 27 26 34 9591190 1:STN:280: DyaK1c3ltlCitw%3D%3D 10.1002/(SICI)1097-4644(1997)27+<26::AID-JCB7>3.0. CO;2-3 (Pubitemid 28222116)
73. Y Abe S Hashimoto T Horie 1999 Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages Pharmacol Res 39 41 47 10051376 1:CAS:528:DyaK1MXhsVelsL8%3D 10.1006/phrs.1998.0404 (Pubitemid 29101333)
74. S Awasthi, et al. 2000 Curcumin-glutathione interactions and the role of human glutathione S-transferase P1-1 Chem Biol Interact 128 19 38 10996298 1:CAS:528:DC%2BD3cXmtlOlsL4%3D 10.1016/S0009-2797(00)00185-X
75. AT Dinkova-Kostova P Talalay 1999 Relation of structure of curcumin analogs to their potencies as inducers of Phase 2 detoxification enzymes Carcinogenesis 20 911 914 10334211 1:CAS:528:DyaK1MXjtVanurg%3D 10.1093/carcin/20.5.911 (Pubitemid 29191875)
76. AT Dinkova-Kostova, et al. 2001 Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups Proc Natl Acad Sci USA 98 3404 3409 11248091 1:CAS:528:DC%2BD3MXit1altLc%3D 10.1073/pnas.051632198 (Pubitemid 32220858)
77. E Balogun, et al. 2003 Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element Biochem J 371 887 895 12570874 1:CAS:528:DC%2BD3sXjtFKlsrY%3D 10.1042/BJ20021619 (Pubitemid 36578887)
78. SS Singhal, et al. 1999 The effect of curcumin on glutathione-linked enzymes in K562 human leukemia cells Toxicol Lett 109 87 95 10514034 1:CAS:528:DyaK1MXlvVWlsrg%3D 10.1016/S0378-4274(99)00124-1 (Pubitemid 29459059)
79. R Motterlini, et al. 2000 Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress Free Radic Biol Med 28 1303 1312 10889462 1:CAS:528:DC%2BD3cXkslSitrk%3D 10.1016/S0891-5849(00)00294-X (Pubitemid 30417475)
80. G Scapagnini, et al. 2002 Caffeic acid phenethyl ester and curcumin: a novel class of heme oxygenase-1 inducers Mol Pharmacol 61 554 561 11854435 1:CAS:528:DC%2BD38XitVSmtbk%3D 10.1124/mol.61.3.554 (Pubitemid 34171921)
81. G Scapagnini, et al. 2006 Curcumin activates defensive genes and protects neurons against oxidative stress Antioxid Redox Signal 8 395 403 16677086 1:CAS:528:DC%2BD28Xkt12ru7o%3D 10.1089/ars.2006.8.395 (Pubitemid 43741311)
82. Scapagnini G et al. (2004) Use of curcumin derivatives or CAPE in the manufacture of a medicament for the treatment of neuroprotective disorders. World Patent Number: WO 2004/075883 A1
83. A Goel AB Kunnumakkara BB Aggarwal 2008 Curcumin as - Curecumin||: from kitchen to clinic Biochem Pharmacol 75 787 809 17900536 1:CAS:528: DC%2BD1cXhsFymtLY%3D 10.1016/j.bcp.2007.08.016 (Pubitemid 351181424)
84. C Yang X Zhang H Fan Y Liu 2009 Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia Brain Res 1282 133 41 19445907 1:CAS:528:DC%2BD1MXotl2ltLo%3D 10.1016/j.brainres.2009.05. 009
85. E Sikora G Scapagnini M Barbagallo 2010 Curcumin, inflammation, ageing and age-related diseases Immun Ageing 7 1 1 20205886 1:CAS:528: DC%2BC3cXht1eitbY%3D 10.1186/1742-4933-7-1
86. V Rajakrishnan, et al. 1999 Neuroprotective role of curcumin from curcuma longa on ethanol induced brain damage Phytother Res 13 571 574 10548748 1:CAS:528:DyaK1MXnvFOmsbk%3D 10.1002/(SICI)1099-1573(199911)13:7<571::AID- PTR494>3.0.CO;2-7 (Pubitemid 29520932)
87. V Chandra, et al. 2001 Incidence of Alzheimer's disease in a rural community in India: the Indo-US study Neurology 57 985 989 11571321 1:STN:280:DC%2BD3MrisVemsQ%3D%3D (Pubitemid 32880190)
88. TP Ng, et al. 2006 Curry consumption and cognitive function in the elderly Am J Epidemiol 164 898 906 16870699 10.1093/aje/kwj267 (Pubitemid 44627275)
89. GP Lim, et al. 2001 The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse J Neurosci 21 8370 8377 11606625 1:CAS:528:DC%2BD3MXnvVeqs7g%3D (Pubitemid 33051435)
90. SA Frautschy, et al. 2001 Phenolic anti-inflammatory antioxidant reversal of Abeta induced cognitive deficits and neuropathology Neurobiol Aging 22 993 1005 11755008 1:CAS:528:DC%2BD3MXptFyksr0%3D 10.1016/S0197-4580(01)00300-1 (Pubitemid 34070638)
91. F Yang, et al. 2005 Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques and reduces amyloid in vivo J Biol Chem 280 5892 5901 15590663 1:CAS:528:DC%2BD2MXhtlClt7w%3D 10.1074/jbc.M404751200 (Pubitemid 40280072)
92. GM Cole B Teter SA Frautschy 2007 Neuroprotective effects of curcumin Adv Exp Med Biol 595 197 212 17569212 10.1007/978-0-387-46401-5-8
93. AN Begum, et al. 2008 Curcumin structure-function, bioavailability and efficacy in models of neuroinflammation and Alzheimer's disease J Pharmacol Exp Ther 326 196 208 18417733 1:CAS:528:DC%2BD1cXotlyltr8%3D 10.1124/jpet.108.137455 (Pubitemid 351872144)
94. L Baum, et al. 2008 Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease J Clin Psychopharmacol 28 110 113 18204357 10.1097/jcp.0b013e318160862c
95. P Michaluart, et al. 1999 Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation Cancer Res 59 2347 2352 10344742 1:CAS:528:DyaK1MXjsVygtLg%3D (Pubitemid 29242281)
96. K Natarajan, et al. 1996 Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B Proc Natl Acad Sci USA 93 9090 9095 8799159 1:CAS:528:DyaK28Xlt1ChsbY%3D 10.1073/pnas.93.17.9090 (Pubitemid 26282023)
97. YJ Chen MS Shiao SY Wang 2001 The antioxidant caffeic acid phenethyl ester induces apoptosis associated with selective scavenging of hydrogen peroxide in human leukemic HL-60 cells Anticancer Drugs 12 143 149 11261888 1:CAS:528:DC%2BD3MXhvVKnsrk%3D 10.1097/00001813-200102000-00008 (Pubitemid 32207364)
98. MT Huang, et al. 1996 Inhibitory effects of caffeic acid phenethyl ester (CAPE) on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion in mouse skin and the synthesis of DNA, RNA and protein in HeLa cells Carcinogenesis 17 761 765 8625488 1:CAS:528:DyaK28XislCgsbo%3D 10.1093/carcin/17.4.761 (Pubitemid 26129690)
99. E Graf 1992 Antioxidant potential of ferulic acid Free Radic Biol Med 13 435 448 1398220 1:CAS:528:DyaK38XmsVCrtLs%3D 10.1016/0891-5849(92)90184-I
100. MJ Qureshi JA Blain 1976 Antioxidant activity in tomato extracts Nucleus Karachi 13 29 33 1:CAS:528:DyaE1MXitFSgsw%3D%3D
101. LC Bourne C Rice-Evans 1998 Biovailability of ferulic acid Biochem Biophys Res Commun 253 222 227 9878519 1:CAS:528:DyaK1MXhs12itA%3D%3D 10.1006/bbrc.1998.9681 (Pubitemid 29026685)
102. R Pannala, et al. 1998 Inhibition of peroxynitrite dependent tyrosine nitration by hydroxycinnamates: nitration or electron donation Free Radic Biol Med 24 594 606 9559872 1:CAS:528:DyaK1cXit1ens70%3D 10.1016/S0891-5849(97)00321- 3 (Pubitemid 28150478)
103. C Castelluccio, et al. 1995 Antioxidant potential of intermediates in phenylpropanoid metabolism in higher plants FEBS Lett 368 188 192 7615079 1:CAS:528:DyaK2MXmvVemtrs%3D 10.1016/0014-5793(95)00639-Q
104. L Bourne C Rice-Evans 1997 The effect of the phenolic antioxidant ferulic acid on the oxidation of low density lipoprotein depends on the pro-oxidant used Free Radic Res 27 337 344 9350437 1:CAS:528:DyaK2sXmvFyku7o%3D 10.3109/10715769709065771 (Pubitemid 27474892)
105. J Kanski, et al. 2002 Ferulic acid antioxidant protection against hydroxyl and peroxyl radical oxidation in synaptosomal and neuronal cell culture systems in vitro: structure-activity studies J Nutr Biochem 13 273 281 12015157 1:CAS:528:DC%2BD38XjsFygtrg%3D 10.1016/S0955-2863(01)00215-7 (Pubitemid 34556688)
106. MN Clifford 1999 Chlorogenic acids and other cinnamates-nature, occurrence and dietary burden J Sci Food Agric 79 362 372 1:CAS:528: DyaK1MXitlOlsbg%3D 10.1002/(SICI)1097-0010(19990301)79:3<362::AID- JSFA256>3.0.CO;2-D (Pubitemid 29150578)
107. PA Kroon G Williamson 1999 Hydroxycinnamates in plants and food: current and future perspectives J Sci Food Agric 79 355 361 1:CAS:528:DyaK1MXitlOlsbs%3D 10.1002/(SICI)1097-0010(19990301)79:3<355::AID-JSFA255>3.0.CO;2-G (Pubitemid 29150577)
108. H Kikuzaki, et al. 2002 Antioxidant properties of ferulic acid and its related compounds J Agric Food Chem 50 2161 2168 11902973 1:CAS:528: DC%2BD38XhsFKjt74%3D 10.1021/jf011348w (Pubitemid 34260027)
109. G Scapagnini, et al. 2004 Ethyl ferulate, a lipophilic polyphenol, induces HO-1 and protects rat neurons against oxidative stress Antioxid Redox Signal 6 811 818 15345140 1:CAS:528:DC%2BD2cXntFCgsLk%3D (Pubitemid 39237933)
110. M Perluigi, et al. 2009 In vivo protective effects of ferulic acid ethyl ester against amyloid-beta peptide 1-42-induced oxidative stress J Neurosci Res 84 418 26 10.1002/jnr.20879 1:CAS:528:DC%2BD28XnvFahsr4%3D (Pubitemid 44126294)
111. J Sano, et al. 2004 Effects of green tea intake on the development of coronary artery disease Circ J 68 665 670 15226633 1:CAS:528: DC%2BD2cXlvFemuro%3D 10.1253/circj.68.665 (Pubitemid 38899601)
112. S Wolfram 2007 Effects of green tea and EGCG on cardiovascular and metabolic health J Am Coll Nutr 26 373 388
113. SB Moyers NB Kumar 2004 Green tea polyphenols and cancer chemoprevention: multiple mechanisms and endpoints for phase II trials Nutr Rev 62 204 211 15212320 10.1111/j.1753-4887.2004.tb00041.x (Pubitemid 38702863)
114. M Boschmann F Thielecke 2007 The effects of epigallocatechin-3-gallate on thermogenesis and fat oxidation in obese men: a pilot study J Am Coll Nutr 26 389 395
115. MA Potenza, et al. 2007 Epigallocatechin gallate, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces bood pressure and protects against myocardial ischemia/reperfusion injury in spontaneously hypertensive rats (SHR) Am J Physiol Endocrinol Metab 292 1378 1387 10.1152/ajpendo.00698.2006 1:CAS:528:DC%2BD2sXls1yisLw%3D (Pubitemid 46684607)
116. S Mandel, et al. 2004 Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3-gallate: implications for neurodegenerative diseases J Neurochem 88 1555 1569 15009657 1:CAS:528:DC%2BD2cXivVCitbY%3D 10.1046/j.1471-4159.2003.02291.x (Pubitemid 38366932)
117. N Khan H Mukhtar 2007 Tea polyphenols for health promotion Life Sci 81 519 533 17655876 1:CAS:528:DC%2BD2sXovFeiu74%3D 10.1016/j.lfs.2007.06.011 (Pubitemid 47212236)
118. S Ahmed, et al. 2002 Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1 beta-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes Free Radic Biol Med 33 1097 1105 12374621 1:CAS:528:DC%2BD38Xns1Sisbc%3D 10.1016/S0891-5849(02)01004-3
119. SJ Kim, et al. 2007 Epigallocatechin-3-gallate suppresses NF-kappaB activation and phosphorylation of p38 MAPK and JNK in human astrocytoma U373MG cells J Nutr Biochem 18 587 596 17446059 1:CAS:528:DC%2BD2sXovFOrsbY%3D 10.1016/j.jnutbio.2006.11.001 (Pubitemid 47212709)
120. N Khan H Mukhtar 2008 Multitargeted therapy of cancer by green tea polyphenols Cancer Lett 269 269 280 18501505 1:CAS:528:DC%2BD1cXhtFWlsrjI 10.1016/j.canlet.2008.04.014
121. R Srividhya, et al. 2008 Attenuation of senescence-induced oxidative exacerbations in aged rat brain by (-)-epigallocatechin-3-gallate Int J Dev Neurosci 26 217 223 18207349 1:CAS:528:DC%2BD1cXhsl2gtrw%3D 10.1016/j.ijdevneu. 2007.12.003
122. MH Kweon, et al. 2006 Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate J Biol Chem 281 33761 33772 16950787 1:CAS:528:DC%2BD28XhtFegsbvP 10.1074/jbc.M604748200 (Pubitemid 46036754)
123. L Romeo, et al. 2009 The major green tea polyphenol, (-)- epigallocatechin-3-gallate, induces heme oxygenase in rat neurons and acts as an effective neuroprotective agent against oxidative stress J Am Coll Nutr 28 492S 499S 20234037 1:CAS:528:DC%2BC3cXlvFOhu7w%3D
124. ZA Shah RC Li AS Ahmad TW Kensler M Yamamoto S Biswal S Doré 2010 The flavanol (-)-epicatechin prevents stroke damage through the Nrf2/HO1 pathway J Cereb Blood Flow Metab 30 12 1951 1961 20442725 1:CAS:528:DC%2BC3cXhsV2gtLzL 10.1038/jcbfm.2010.53